title: Ebola clinical trials: Five lessons learned and a way forward.
authors.affiliation: Duke University, Durham, NC, USA n.thielman@duke.edu.
authors.forename: Nathan M
authors.initials: NM
authors.lastname: Thielman
authors.affiliation: Duke University, Durham, NC, USA.
authors.forename: Coleen K
authors.initials: CK
authors.lastname: Cunningham
authors.affiliation: Duke University, Durham, NC, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Woods
authors.affiliation: Duke University, Durham, NC, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Petzold
authors.affiliation: ClinicalRM, Hinckley, OH, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Sprenz
authors.affiliation: College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
authors.forename: James
authors.initials: J
authors.lastname: Russell
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics / Q000379:methods* / Q000458:organization & administration; D004196:Disease Outbreaks; D004630:Emergencies; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007988:Liberia / Q000453:epidemiology; D012107:Research Design; D012807:Sierra Leone / Q000453:epidemiology